Navigation Links
Transvaginal Mesh Lawsuit News: Bernstein Liebhard LLP Notes Order Reopening Discovery in Federal C.R. Bard Vaginal Mesh Litigation

New York, New York (PRWEB) May 13, 2013

Transvaginal mesh lawsuits involving products manufactured by C.R. Bard, Inc. continue to move forward in a multidistrict litigation underway in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP reports. According to an Order issued on May 2nd, the Court has reopened discovery in the proceeding to allow for the deposition of a C.R. Bard executive regarding the alleged use of a prohibited raw polypropylene resin in its mesh products. In doing so, the Court found that the “sheer volume of the production” had prevented plaintiffs from previously discovering emails from the executive that discussed the resin. (In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation “MDL No. 2187”)

“We are pleased the Court agreed to reopen discovery in this litigation. We look forward to the continued deposition of this witness,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. Firm partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committee in the federal C.R. Bard vaginal mesh litigation.

C.R. Bard Vaginal Mesh Lawsuits

Pelvic mesh products manufactured by C.R. Bard and other companies have been the subject of growing litigation since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious vaginal mesh injuries over a three year period. In July 2011, the FDA warned that there had been a five-fold increase in reports of serious complications associated with the use of pelvic mesh in prolapse repair since the 2008 alert. According to the agency, the most frequently-reported injuries include mesh erosion through vaginal tissue, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. There were also reports of bowel, bladder, and blood vessel perforation during insertion, the FDA said. *

According to an Order issued in the Southern District of West Virginia on March 7th, four Bard Avaulta transvaginal mesh lawsuits have been selected for the litigation’s bellwether trials, with the first scheduled to begin on June 11, 2013. Several other vaginal mesh litigations are also underway in West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2325; In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation - MDL No. 2326; and In re: Ethicon, Inc. Pelvic Repair Systems Products Liability Litigation - MDL No. 2327. Bernstein Liebhard LLP, Jeffrey S. Grand, is also serving on the Plaintiffs’ Steering Committees in these litigations.

In addition to the federal litigations underway in West Virginia, additional transvaginal mesh lawsuits are pending in consolidated proceedings now underway in New Jersey Superior Court, Atlantic County, involving products manufactured by C.R. Bard and Johnson & Johnson’s Ethicon unit. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). Mr. Grand is also serving as Co-Liaison Counsel in both of these litigations. The litigations’ first trial involving a C.R. Bard vaginal mesh lawsuit is scheduled to head to trial in September. However, in March, the jury hearing the proceeding’s first Ethicon mesh trial awarded more than $11 million, including punitive damages, to the Plaintiff. Mr. Grand also served on the trial team in that case. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey)

Victims of alleged vaginal mesh complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding transvaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.


About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
2. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
3. US Drug Watchdog Now Fears the Numbers of Transvaginal Mesh Product Failure Victims Will Grow and They Offer Victims the Names of the Best Lawyers-Who Will All Be Women
4. US Drug Watchdog Now Urges Transvaginal Mesh, Tape Or Sling Failure Victims To Call Them For The Names Of The Best Possible Attorneys-Who Are All Also Women-Get Help Now
5. US Drug Watchdog Now Offers All Victims Of A Transvaginal Mesh, Sling, or Tape Failure The Names And Contacts Of The Best Possible National Caliber Lawyers Who Are Women
6. US Drug Watchdog Expands Their Transvaginal Mesh Initiative Because Of The Potential Number Of Victims & They are Offering the Names of the Best Women Attorneys To Help
7. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
8. US Drug Watchdog Now Urges All Victims of a Transvaginal Sling, Tape, or Mesh Failure to Call Them for the Names of National Caliber Women Attorneys-Get Help Now
9. Wright & Schulte LLC Files Transvaginal Mesh Lawsuit on Behalf of Woman Allegedly Injured by Align Urethral Support System
10. US Drug Watchdog Now Offers Women Who Are Victims Of A Transvaginal Mesh, Sling, or Tape Medical Product Failure the Names of The Best Possible Lawyers-Who are All Women
11. US Drug Watchdog Is Expanding Their Effort To Ensure Victims Transvaginal Sling,Tape,Or Mesh Failure Get The Names And Contacts of Top Caliber Attorneys-Who Are All Women
Post Your Comments:
(Date:12/1/2015)... ... ... Hospital Tampa is the first health care provider in the region to offer the ... is a vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult ... least 40 to 45 kg, or a BMI of at least 35 to 39.9 kg ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Dr. Paul Vitenas, ... Cosmetic Surgery, has been named by MedEsthetics magazine as the Best Single Physician Practice ... best among the many elite aesthetic physicians honored by the industry publication. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Annual 2015 Golden Bridge Business Awards under the New Products and Services category ... web based sample management software that helps labs organize data and ...
(Date:12/1/2015)... ... 2015 , ... For many X-rays taken at hospitals, doctors’ ... by the radiologist. The marking utensils are so small, however, they are difficult ... way to alleviate this problem. , He developed the patent-pending MARK N SHOW ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been awarded a fixed price per sprint agile development contract to support ... $34 million over five years, provides software engineering, infrastructure, as well as operations ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015  Following an ... (NASDAQ: OGXI ) announced today that its Phase ... interim futility analysis of the intent-to-treat (ITT) population. In ... identified by the DMC. Both the DMC and OncoGenex ... expected in the second half of 2016, depending on ...
(Date:12/1/2015)... , Dec. 1, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® blood purification technology to reduce ... world, today announced that Dr. Phillip Chan ... to participate in the LD Micro Main Event ... Conference, both of which will be held in ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 /PRNewswire/ ... ) today announced that its Chief Executive ... at the Oppenheimer Annual Healthcare Conference in ... participate in the conference through a webcast ... , --> ...
Breaking Medicine Technology: